Oliver Stone worried about Michael Douglas’ ‘precarious’ health
October 13th, 2010 - 2:53 pm ICT by ANILondon, Oct 13 (ANI): Director Oliver Stone has said that he is concerned about the ‘precarious’ health of actor Michael Douglas, who is fighting throat cancer.
Stone voiced his concerns regarding Douglas’ health while on a promotional tour for his latest film, which stars the actor, reports the Telegraph.
Douglas reprised his role as stock trader Gordon Gekko in Stone’s latest film ‘Wall Street: Money Never Sleeps’.
Douglas was meant was meant to accompany him on a promotion tour in Europe, but Stone said Douglas remained in the US for further cancer treatments.
Publicist Allen Burry said Douglas finished his treatments last week. (ANI)
- Michael Douglas' health is precarious: Oliver Stone - Oct 14, 2010
- 8-Week Cancer Treatment Over, Michael Douglas Is Back Home - Oct 09, 2010
- Michael Douglas Is In Precarious Condition, Says Oliver Stone - Oct 14, 2010
- Cancer-stricken Michael Douglas 'to attend Wall Street premiere' - Sep 19, 2010
- Michael Douglas at the premiere of Wall Street - Sep 23, 2010
- Douglas' cancer treatment almost complete - Oct 07, 2010
- Chemotherapy limits my day, says Michael Douglas - Sep 10, 2010
- Is It A Losing Battle For Michael Douglas Against Throat Cancer? - Oct 14, 2010
- 'Douglas is not close to his deathbed', says pal - Oct 15, 2010
- Movie Review: Wall Street (2010) - Sep 25, 2010
- Javier Bardem quits 'Wall Street' sequel - Jul 25, 2009
- Cancer-stricken Michael Douglas blames illness on stress - Sep 23, 2010
- Michael Douglas to attend Golden Globes ceremony - Dec 20, 2010
- Michael Douglas to complete cancer treatment this week - Oct 07, 2010
- Michael Douglas Geared Up To Experience Piano Lessons For His Upcoming Film, ‘Liberace’ - Jan 15, 2011
Tags: actor michael douglas, burry, cancer treatments, director oliver stone, gordon gekko, Health Science, london, michael douglas, oliver stone, promotion tour, publicist, stock trader, street money, telegraph, throat cancer, tour in europe, wall street
